REPORTS

Let’s Pullulate and Expand Your Business

Global Duchenne Muscular Dystrophy Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Dec 26, 2019  |  137 PAGES  |  REPORT CODE: CMM258134
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Duchenne Muscular Dystrophy is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period. The research provides insights for the global Duchenne Muscular Dystrophy market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Duchenne Muscular Dystrophy industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Duchenne Muscular Dystrophy Market Segmentations:

By Players:

  • Daiichi Sankyo

  • Genethon

  • Pfizer

  • Solid Biosciences

  • Wave Life

  • Summit Therapeutics

  • ITALFARMACO

  • Santhera Pharmaceuticals

  • BioMarin

  • NS Pharma

  • Bristol-Myers Squibb

  • Sarepta Therapeutics

  • PTC Therapeutics

  • ReveraGen BioPharma

  • FibroGen

By Types:

  • Deflazacort

  • Prednisone

  • Others

By End-User:

  • Male

  • Female

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Duchenne Muscular Dystrophy Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Duchenne Muscular Dystrophy Market Share by Types

    • 1.3.2 Global Duchenne Muscular Dystrophy Market Size and Growth Rate of Deflazacort from 2014 to 2026

    • 1.3.3 Global Duchenne Muscular Dystrophy Market Size and Growth Rate of Prednisone from 2014 to 2026

    • 1.3.4 Global Duchenne Muscular Dystrophy Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Duchenne Muscular Dystrophy Market Share by End-Users

    • 1.4.2 Global Duchenne Muscular Dystrophy Market Size and Growth Rate of Male from 2014 to 2026

    • 1.4.3 Global Duchenne Muscular Dystrophy Market Size and Growth Rate of Female from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Duchenne Muscular Dystrophy Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Duchenne Muscular Dystrophy Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Duchenne Muscular Dystrophy by Major Types

    • 3.4.1 Market Size and Growth Rate of Deflazacort

    • 3.4.2 Market Size and Growth Rate of Prednisone

    • 3.4.3 Market Size and Growth Rate of Others

4 Segmentation of Duchenne Muscular Dystrophy Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Duchenne Muscular Dystrophy by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Duchenne Muscular Dystrophy for Male

    • 4.4.2 Market Size and Growth Rate of Duchenne Muscular Dystrophy for Female

5 Market Analysis by Major Regions

  • 5.1 Global Duchenne Muscular Dystrophy Production Analysis by Major Regions

  • 5.2 Global Duchenne Muscular Dystrophy Consumption Analysis by Major Regions

  • 5.3 Global Duchenne Muscular Dystrophy Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Duchenne Muscular Dystrophy Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Duchenne Muscular Dystrophy Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Duchenne Muscular Dystrophy Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Production, Import, Consumption and Export Analysis

6 Product Commodity of Duchenne Muscular Dystrophy Market in Major Countries

  • 6.1 Top 5 Export Countries in Duchenne Muscular Dystrophy market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Duchenne Muscular Dystrophy market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Duchenne Muscular Dystrophy market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Duchenne Muscular Dystrophy market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Duchenne Muscular Dystrophy market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Duchenne Muscular Dystrophy market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Duchenne Muscular Dystrophy Landscape Analysis

  • 7.1 North America Duchenne Muscular Dystrophy Landscape Analysis by Major Types

  • 7.2 North America Duchenne Muscular Dystrophy Landscape Analysis by Major End-Users

  • 7.3 North America Duchenne Muscular Dystrophy Landscape Analysis by Major Countries

    • 7.3.1 United States Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 7.3.2 Canada Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 7.3.3 Mexico Duchenne Muscular Dystrophy Market Volume and Growth Rate

8 Europe Duchenne Muscular Dystrophy Landscape Analysis

  • 8.1 Europe Duchenne Muscular Dystrophy Landscape Analysis by Major Types

  • 8.2 Europe Duchenne Muscular Dystrophy Landscape Analysis by Major End-Users

  • 8.3 Europe Duchenne Muscular Dystrophy Landscape Analysis by Major Countries

    • 8.3.1 Germany Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 8.3.2 UK Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 8.3.3 France Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 8.3.4 Italy Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 8.3.6 Spain Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 8.3.7 Belgium Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 8.3.8 Poland Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 8.3.9 Russia Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 8.3.10 Turkey Duchenne Muscular Dystrophy Market Volume and Growth Rate

9 Asia Pacific Duchenne Muscular Dystrophy Landscape Analysis

  • 9.1 Asia Pacific Duchenne Muscular Dystrophy Landscape Analysis by Major Types

  • 9.2 Asia Pacific Duchenne Muscular Dystrophy Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Duchenne Muscular Dystrophy Landscape Analysis by Major Countries

    • 9.3.1 China Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 9.3.2 Japan Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 9.3.4 India Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 9.3.6 South Korea Duchenne Muscular Dystrophy Market Volume and Growth Rate

10 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Duchenne Muscular Dystrophy Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 10.3.2 Brazil Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 10.3.3 Nigeria Duchenne Muscular Dystrophy Market Volume and Growth Rate

    • 10.3.4 South Africa Duchenne Muscular Dystrophy Market Volume and Growth Rate 

    • 10.3.5 Argentina Duchenne Muscular Dystrophy Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Daiichi Sankyo

    • 11.1.1 Daiichi Sankyo Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Genethon

    • 11.2.1 Genethon Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Pfizer

    • 11.3.1 Pfizer Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Solid Biosciences

    • 11.4.1 Solid Biosciences Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Wave Life

    • 11.5.1 Wave Life Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Summit Therapeutics

    • 11.6.1 Summit Therapeutics Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 ITALFARMACO

    • 11.7.1 ITALFARMACO Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Santhera Pharmaceuticals

    • 11.8.1 Santhera Pharmaceuticals Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 BioMarin

    • 11.9.1 BioMarin Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 NS Pharma

    • 11.10.1 NS Pharma Company Profile and Development Status

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Bristol-Myers Squibb

    • 11.11.1 Bristol-Myers Squibb Company Profile and Development Status

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Sarepta Therapeutics

    • 11.12.1 Sarepta Therapeutics Company Profile and Development Status

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 PTC Therapeutics

    • 11.13.1 PTC Therapeutics Company Profile and Development Status

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 ReveraGen BioPharma

    • 11.14.1 ReveraGen BioPharma Company Profile and Development Status

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 FibroGen

    • 11.15.1 FibroGen Company Profile and Development Status

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 99 Figures and 155 Tables)

  • Figure Product Picture

  • Figure Global Duchenne Muscular Dystrophy Market Size and Growth Rate of Deflazacort from 2014 to 2026

  • Figure Global Duchenne Muscular Dystrophy Market Size and Growth Rate of Prednisone from 2014 to 2026

  • Figure Global Duchenne Muscular Dystrophy Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Duchenne Muscular Dystrophy Market Size and Growth Rate of Male from 2014 to 2026

  • Figure Global Duchenne Muscular Dystrophy Market Size and Growth Rate of Female from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Duchenne Muscular Dystrophy Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Duchenne Muscular Dystrophy Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Duchenne Muscular Dystrophy

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Duchenne Muscular Dystrophy by Different Types from 2014 to 2026

  • Table Consumption Share of Duchenne Muscular Dystrophy by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Deflazacort

  • Figure Market Size and Growth Rate of Prednisone

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Duchenne Muscular Dystrophy by Different End-Users from 2014 to 2026

  • Table Consumption Share of Duchenne Muscular Dystrophy by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Male

  • Figure Market Size and Growth Rate of Female

  • Table Global Duchenne Muscular Dystrophy Production by Major Regions

  • Table Global Duchenne Muscular Dystrophy Production Share by Major Regions

  • Figure Global Duchenne Muscular Dystrophy Production Share by Major Regions in 2014

  • Figure Global Duchenne Muscular Dystrophy Production Share by Major Regions in 2018

  • Figure Global Duchenne Muscular Dystrophy Production Share by Major Regions in 2026

  • Table Global Duchenne Muscular Dystrophy Consumption by Major Regions

  • Table Global Duchenne Muscular Dystrophy Consumption Share by Major Regions

  • Figure Global Duchenne Muscular Dystrophy Consumption Share by Major Regions in 2014

  • Figure Global Duchenne Muscular Dystrophy Consumption Share by Major Regions in 2018

  • Figure Global Duchenne Muscular Dystrophy Consumption Share by Major Regions in 2026

  • Table North America Duchenne Muscular Dystrophy Production, Import, Consumption and Export Analysis

  • Table Europe Duchenne Muscular Dystrophy Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Duchenne Muscular Dystrophy Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Duchenne Muscular Dystrophy market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Duchenne Muscular Dystrophy market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Duchenne Muscular Dystrophy market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Duchenne Muscular Dystrophy market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Duchenne Muscular Dystrophy Consumption by Types from 2014 to 2026

  • Table North America Duchenne Muscular Dystrophy Consumption Share by Types from 2014 to 2026

  • Figure North America Duchenne Muscular Dystrophy Consumption Share by Types in 2014

  • Figure North America Duchenne Muscular Dystrophy Consumption Share by Types in 2018

  • Figure North America Duchenne Muscular Dystrophy Consumption Share by Types in 2026

  • Table North America Duchenne Muscular Dystrophy Consumption by End-Users from 2014 to 2026

  • Table North America Duchenne Muscular Dystrophy Consumption Share by End-Users from 2014 to 2026

  • Figure North America Duchenne Muscular Dystrophy Consumption Share by End-Users in 2014

  • Figure North America Duchenne Muscular Dystrophy Consumption Share by End-Users in 2018

  • Figure North America Duchenne Muscular Dystrophy Consumption Share by End-Users in 2026

  • Table North America Duchenne Muscular Dystrophy Consumption by Major Countries from 2014 to 2026

  • Table North America Duchenne Muscular Dystrophy Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2014

  • Figure North America Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2018

  • Figure North America Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2026

  • Figure United States Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Duchenne Muscular Dystrophy Consumption by Types from 2014 to 2026

  • Table Europe Duchenne Muscular Dystrophy Consumption Share by Types from 2014 to 2026

  • Figure Europe Duchenne Muscular Dystrophy Consumption Share by Types in 2014

  • Figure Europe Duchenne Muscular Dystrophy Consumption Share by Types in 2018

  • Figure Europe Duchenne Muscular Dystrophy Consumption Share by Types in 2026

  • Table Europe Duchenne Muscular Dystrophy Consumption by End-Users from 2014 to 2026

  • Table Europe Duchenne Muscular Dystrophy Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Duchenne Muscular Dystrophy Consumption Share by End-Users in 2014

  • Figure Europe Duchenne Muscular Dystrophy Consumption Share by End-Users in 2018

  • Figure Europe Duchenne Muscular Dystrophy Consumption Share by End-Users in 2026

  • Table Europe Duchenne Muscular Dystrophy Consumption by Major Countries from 2014 to 2026

  • Table Europe Duchenne Muscular Dystrophy Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2014

  • Figure Europe Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2018

  • Figure Europe Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2026

  • Figure Germany Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure France Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Duchenne Muscular Dystrophy Consumption by Types from 2014 to 2026

  • Table Asia Pacific Duchenne Muscular Dystrophy Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Duchenne Muscular Dystrophy Consumption Share by Types in 2014

  • Figure Asia Pacific Duchenne Muscular Dystrophy Consumption Share by Types in 2018

  • Figure Asia Pacific Duchenne Muscular Dystrophy Consumption Share by Types in 2026

  • Table Asia Pacific Duchenne Muscular Dystrophy Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Duchenne Muscular Dystrophy Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Duchenne Muscular Dystrophy Consumption Share by End-Users in 2014

  • Figure Asia Pacific Duchenne Muscular Dystrophy Consumption Share by End-Users in 2018

  • Figure Asia Pacific Duchenne Muscular Dystrophy Consumption Share by End-Users in 2026

  • Table Asia Pacific Duchenne Muscular Dystrophy Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Duchenne Muscular Dystrophy Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2026

  • Figure China Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandDuchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure India Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Duchenne Muscular Dystrophy Consumption Share by Major Countries in 2026

  • Figure GCC Countries Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Duchenne Muscular Dystrophy Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Daiichi Sankyo

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo

  • Figure Sales and Growth Rate Analysis of Daiichi Sankyo

  • Figure Revenue and Market Share Analysis of Daiichi Sankyo

  • Table Product and Service Introduction of Daiichi Sankyo

  • Table Company Profile and Development Status of Genethon

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genethon

  • Figure Sales and Growth Rate Analysis of Genethon

  • Figure Revenue and Market Share Analysis of Genethon

  • Table Product and Service Introduction of Genethon

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of Solid Biosciences

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Solid Biosciences

  • Figure Sales and Growth Rate Analysis of Solid Biosciences

  • Figure Revenue and Market Share Analysis of Solid Biosciences

  • Table Product and Service Introduction of Solid Biosciences

  • Table Company Profile and Development Status of Wave Life

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wave Life

  • Figure Sales and Growth Rate Analysis of Wave Life

  • Figure Revenue and Market Share Analysis of Wave Life

  • Table Product and Service Introduction of Wave Life

  • Table Company Profile and Development Status of Summit Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Summit Therapeutics

  • Figure Sales and Growth Rate Analysis of Summit Therapeutics

  • Figure Revenue and Market Share Analysis of Summit Therapeutics

  • Table Product and Service Introduction of Summit Therapeutics

  • Table Company Profile and Development Status of ITALFARMACO

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ITALFARMACO

  • Figure Sales and Growth Rate Analysis of ITALFARMACO

  • Figure Revenue and Market Share Analysis of ITALFARMACO

  • Table Product and Service Introduction of ITALFARMACO

  • Table Company Profile and Development Status of Santhera Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Santhera Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Santhera Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Santhera Pharmaceuticals

  • Table Product and Service Introduction of Santhera Pharmaceuticals

  • Table Company Profile and Development Status of BioMarin

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMarin

  • Figure Sales and Growth Rate Analysis of BioMarin

  • Figure Revenue and Market Share Analysis of BioMarin

  • Table Product and Service Introduction of BioMarin

  • Table Company Profile and Development Status of NS Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NS Pharma

  • Figure Sales and Growth Rate Analysis of NS Pharma

  • Figure Revenue and Market Share Analysis of NS Pharma

  • Table Product and Service Introduction of NS Pharma

  • Table Company Profile and Development Status of Bristol-Myers Squibb

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

  • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

  • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

  • Table Product and Service Introduction of Bristol-Myers Squibb

  • Table Company Profile and Development Status of Sarepta Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sarepta Therapeutics

  • Figure Sales and Growth Rate Analysis of Sarepta Therapeutics

  • Figure Revenue and Market Share Analysis of Sarepta Therapeutics

  • Table Product and Service Introduction of Sarepta Therapeutics

  • Table Company Profile and Development Status of PTC Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PTC Therapeutics

  • Figure Sales and Growth Rate Analysis of PTC Therapeutics

  • Figure Revenue and Market Share Analysis of PTC Therapeutics

  • Table Product and Service Introduction of PTC Therapeutics

  • Table Company Profile and Development Status of ReveraGen BioPharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ReveraGen BioPharma

  • Figure Sales and Growth Rate Analysis of ReveraGen BioPharma

  • Figure Revenue and Market Share Analysis of ReveraGen BioPharma

  • Table Product and Service Introduction of ReveraGen BioPharma

  • Table Company Profile and Development Status of FibroGen

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FibroGen

  • Figure Sales and Growth Rate Analysis of FibroGen

  • Figure Revenue and Market Share Analysis of FibroGen

  • Table Product and Service Introduction of FibroGen


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top